org placeholder image

Jefte Drijvers

Director, Program Leadership at Abata Therapeutics

  • LinkedIn
map
ABATA THERAPEUTICS

ABATA THERAPEUTICS

  • description Description
    We are bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis a state o...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Abata Therapeutics Org Chart and Mapping

Employees

Krish Parekh

Technical Operations Co-Op

Jefte Drijvers

Director, Program Leadership

Stephen Sofen

Chief Technical Officer

Irina Leaf

Director, Translational Medicine

Stephanie Woodall

Senior Director, Quality and Regulatory

Geetha Mylvaganam

Senior Director, Head of Research

Cristin Berkey

Senior Director of Intellectual Property and Contracts

Frequently Asked Questions Regarding Jefte Drijvers

Answer: Jefte Drijvers works for Abata Therapeutics as Director, Program Leadership

Answer: Jefte Drijvers’s role in Abata Therapeutics is Director, Program Leadership

Answer: Jefte Drijvers's email address is j***@gmail.com

Answer: Jefte Drijvers's business email address is j****@thirdrockventures.com

Answer: Jefte Drijvers’s direct phone number is (***)-***-****

Answer: Jefte Drijvers works in the industry of: Biotechnology

Answer: Jefte Drijvers works Abata Therapeutics located at 245 1st St, Cambridge, Massachusetts, 02142, United States

Answer: Abata Therapeutics's Director, Program Leadership is Jefte Drijvers

Answer: Jefte Drijvers contact details:

  • Phone number  :  (***)-***-****
  • Email  :  j****@thirdrockventures.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access